Squarepoint’s BioLife Solutions BLFS Stock Holding History

Squarepoint’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-54,633	Closed	-$1.39M	–	4287
2025 Q3	$1.39M	Sell	54,633 -14,176	-21%	-$336K	﹤0.01%	2392
2025 Q2	$1.48M	Buy	+68,809	New	+$1.55M	﹤0.01%	2321
2024 Q4	–	Sell	-31,598	Closed	-$791K	–	5030
2024 Q3	$791K	Sell	31,598 -16,998	-35%	-$401K	﹤0.01%	2781
2024 Q2	$1.04M	Buy	+48,596	New	+$943K	﹤0.01%	2523
2024 Q1	–	Sell	-52,980	Closed	-$861K	–	4046
2023 Q4	$861K	Buy	52,980 +41,854	+376%	+$534K	﹤0.01%	2629
2023 Q3	$154K	Buy	+11,126	New	+$175K	﹤0.01%	3480
2022 Q1	–	Sell	-25,816	Closed	-$962K	–	2841
2021 Q4	$962K	Buy	+25,816	New	+$1.11M	﹤0.01%	1722
2021 Q2	–	Sell	-24,865	Closed	-$895K	–	3238
2021 Q1	$895K	Buy	+24,865	New	+$983K	0.01%	1599
2020 Q3	–	Sell	-19,295	Closed	-$315K	–	2496
2020 Q2	$315K	Sell	19,295 -33,447	-63%	-$461K	0.01%	1570
2020 Q1	$501K	Buy	+52,742	New	+$724K	0.01%	1041

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Squarepoint's BLFS Position: Q4 2025 in Review

Squarepoint sold out of BioLife Solutions (BLFS) in Q4 2025, closing a stake of 54,633 shares — an estimated $1.39M sold.

Squarepoint first reported a position in BLFS in Q1 2020 and held it in 10 quarters. The position peaked at $1.48M in Q2 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q4 2025.

Squarepoint reported no remaining BioLife Solutions position as of Q4 2025 after selling out during the quarter.
Squarepoint sold 54,633 BioLife Solutions shares in Q4 2025, an estimated $1.39M.
Squarepoint first reported a position in BioLife Solutions in Q1 2020 and held it in 10 quarters.
Squarepoint's BioLife Solutions position peaked at $1.48M in Q2 2025.
187 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.